Evidence map›Paper›PMID 32338717›Full record

ArticleJAMA internal medicine2020

Association of a Province-Wide Intervention With Salt Intake and Hypertension in Shandong Province, China, 2011-2016.

Aiqiang Xu, Jixiang Ma, Xiaolei Guo, Linhong Wang, Jing Wu, Jiyu Zhang, Yamin Bai, Jianwei Xu, Zilong Lu, Zhongji Xu and 29 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in JAMA internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Highlights of the 2024 Chinese hypertension guidelines.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

39 authors at 9 institutions in 2 countries.

Aiqiang XuShandong Center for Disease Control and Prevention, and Academy of Preventive Medicine, Shandong University, Jinan, China.
Jixiang MaChinese Center for Disease Control and Prevention, Beijing, China.
Xiaolei GuoShandong Center for Disease Control and Prevention, and Academy of Preventive Medicine, Shandong University, Jinan, China.
Linhong WangNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jing WuNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jiyu ZhangShandong Center for Disease Control and Prevention, and Academy of Preventive Medicine, Shandong University, Jinan, China.
Yamin BaiNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jianwei XuNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zilong LuShandong Center for Disease Control and Prevention, and Academy of Preventive Medicine, Shandong University, Jinan, China.
Zhongji XuChinese Center for Disease Control and Prevention, Beijing, China.
Xiaochang ZhangChinese Center for Disease Control and Prevention, Beijing, China.
Gangqiang DingNational Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing, China.
Yuling HongDivision for Heart Disease and Stroke Prevention Centers for Disease Control and Prevention, Atlanta, Georgia.
Fengjun DuChinese Center for Disease Control and Prevention, Beijing, China.
Yangfeng WuPeking University Clinical Research Institute, Beijing, China.
Liuxia YanNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Junli TangShandong Center for Disease Control and Prevention, and Academy of Preventive Medicine, Shandong University, Jinan, China.
Xiaoning CaiNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jing DongShandong Center for Disease Control and Prevention, and Academy of Preventive Medicine, Shandong University, Jinan, China.
Chunxiao XuShandong Center for Disease Control and Prevention, and Academy of Preventive Medicine, Shandong University, Jinan, China.
Jie RenShandong Center for Disease Control and Prevention, and Academy of Preventive Medicine, Shandong University, Jinan, China.
Xi ChenShandong Center for Disease Control and Prevention, and Academy of Preventive Medicine, Shandong University, Jinan, China.
Congcong GaoShandong Center for Disease Control and Prevention, and Academy of Preventive Medicine, Shandong University, Jinan, China.
Bingyin ZhangShandong Center for Disease Control and Prevention, and Academy of Preventive Medicine, Shandong University, Jinan, China.
Quanhe YangDivision for Heart Disease and Stroke Prevention Centers for Disease Control and Prevention, Atlanta, Georgia.
Ronald MoolenaarDivision of Global Health Protection Centers for Disease Control and Prevention, Atlanta, Georgia.
Ying CaiDivision of Global Health Protection Centers for Disease Control and Prevention, Atlanta, Georgia.
Sandra L JacksonDivision for Heart Disease and Stroke Prevention Centers for Disease Control and Prevention, Atlanta, Georgia.
Gaoqiang XiePeking University Clinical Research Institute, Beijing, China.
Shicheng YuChinese Center for Disease Control and Prevention, Beijing, China.
Jing CuiChina National Salt Industry Company Limited, Beijing, China.
Zengwu WangDivision of Preventive and Community Health, National Center for Cardiovascular Disease, The State Key Laboratory of Cardiovascular Disease, National Clinical Research Center of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Liyun ZhaoNational Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing, China.
Lahong JuNational Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing, China.
Danyang ShenChinese Center for Disease Control and Prevention, Beijing, China.
Shumei YunMissouri Department of Mental Health, Jefferson City.
Xiaofeng LiangChinese Center for Disease Control and Prevention, Beijing, China.
Zhenqiang BiShandong Center for Disease Control and Prevention, and Academy of Preventive Medicine, Shandong University, Jinan, China.
Yu WangChinese Center for Disease Control and Prevention, Beijing, China.
Chinese Center For Disease Control and Prevention · CNShandong Center for Disease Control and Prevention · CNNational Center for Chronic and Noncommunicable Disease Control and Prevention · CNCenters for Disease Control and Prevention · USShandong University · CNPeking University · CNChina National Salt Industry Corporation (China) · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNMissouri Department of Mental Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: High salt intake is associated with hypertension, which is a leading modifiable risk factor for cardiovascular disease. Objective: To assess the association of a government-led, multisectoral, and population-based intervention with reduced salt intake and blood pressure in Shandong Province, China. Design, Setting, and Participants: This cross-sectional study used data from the Shandong-Ministry of Health Action on Salt and Hypertension (SMASH) program, a 5-year intervention to reduce sodium consumption in Shandong Province, China. Two representative samples of adults (aged 18-69 years) were surveyed in 2011 (15 350 preintervention participants) and 2016 (16 490 postintervention participants) to examine changes in blood pressure, and knowledge, attitudes, and behaviors related to sodium intake. Urine samples were collected from random subsamples (2024 preintervention participants and 1675 postintervention participants) for measuring sodium and potassium excretion. Data were analyzed from January 20, 2017, to April 9, 2019. Interventions: Media campaigns, distribution of scaled salt spoons, promotion of low-sodium products in markets and restaurants, and activities to support household sodium reduction and school-based sodium reduction education. Main Outcomes and Measures: The primary outcome was change in urinary sodium excretion. Secondary outcomes were changes in potassium excretion, blood pressure, and knowledge, attitudes, and behaviors. Outcomes were adjusted for likely confounders. Means (95% CIs) and percentages were weighted. Results: Among 15 350 participants in 2011, 7683 (50.4%) were men and the mean age was 40.7 years (95% CI, 40.2-41.2 years); among 16 490 participants in 2016, 8077 (50.7%) were men and the mean age was 42.8 years (95% CI, 42.5-43.1 years). Among participants with 24-hour urine samples, 1060 (51.8%) were men and the mean age was 40.9 years (95% CI, 40.5-41.3 years) in 2011 and 836 (50.7%) were men and the mean age was 40.7 years (95% CI, 40.1-41.4 years) in 2016. The 24-hour urinary sodium excretion decreased 25% from 5338 mg per day (95% CI, 5065-5612 mg per day) in 2011 to 4013 mg per day (95% CI, 3837-4190 mg per day) in 2016 (P < .001), and potassium excretion increased 15% from 1607 mg per day (95% CI, 1511-1704 mg per day) to 1850 mg per day (95% CI, 1771-1929 mg per day) (P < .001). Adjusted mean systolic blood pressure among all participants decreased from 131.8 mm Hg (95% CI, 129.8-133.8 mm Hg) to 130.0 mm Hg (95% CI, 127.7-132.4 mm Hg) (P = .04), and diastolic blood pressure decreased from 83.9 mm Hg (95% CI, 82.6-85.1 mm Hg) to 80.8 mm Hg (95% CI, 79.4-82.1 mm Hg) (P < .001). Knowledge, attitudes, and behaviors associated with dietary sodium reduction and hypertension improved significantly. Conclusions and Relevance: The findings suggest that a government-led and population-based intervention in Shandong, China, was associated with significant decreases in dietary sodium intake and a modest reduction in blood pressure. The results of SMASH may have implications for sodium reduction and blood pressure control in other regions of China and worldwide.

Indexed as

AdolescentAdultAgedBlood PressureChinaCross-Sectional StudiesDiet, Sodium-RestrictedFemaleHumansHypertensionIncidenceMaleMiddle AgedPrognosisRisk FactorsSodium Chloride, DietarySodium Chloride, Dietary

Identifiers

PMID32338717
PMCPMC7186913
OpenAlexW3017551314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.